133 related articles for article (PubMed ID: 36043912)
21. Interdomain interaction of Stat3 regulates its Src homology 2 domain-mediated receptor binding activity.
Zhang T; Seow KT; Ong CT; Cao X
J Biol Chem; 2002 May; 277(20):17556-63. PubMed ID: 11872739
[TBL] [Abstract][Full Text] [Related]
22. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
Ernst M; Novak U; Nicholson SE; Layton JE; Dunn AR
J Biol Chem; 1999 Apr; 274(14):9729-37. PubMed ID: 10092661
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of proliferation of some but not all human colon carcinoma cell lines by immobilized hepatic asialoglycoprotein receptor 1.
Fang J; Izawa R; Gomez-Santos L; Ueno S; Sawaguchi T; Usami K; Nodera Y; Takeuchi H; Ohashi Y; Higashi N; Irimura T
Oncol Res; 2009; 17(10):437-45. PubMed ID: 19725223
[TBL] [Abstract][Full Text] [Related]
24. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract][Full Text] [Related]
25. Role of the TAK1-NLK-STAT3 pathway in TGF-beta-mediated mesoderm induction.
Ohkawara B; Shirakabe K; Hyodo-Miura J; Matsuo R; Ueno N; Matsumoto K; Shibuya H
Genes Dev; 2004 Feb; 18(4):381-6. PubMed ID: 15004007
[TBL] [Abstract][Full Text] [Related]
26. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.
Lu G; Tian S; Sun Y; Dong J; Wang N; Zeng J; Nie Y; Wu K; Han Y; Feng B; Shang Y
Theranostics; 2021; 11(5):2460-2474. PubMed ID: 33500736
[No Abstract] [Full Text] [Related]
27. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
Theranostics; 2018; 8(1):61-77. PubMed ID: 29290793
[No Abstract] [Full Text] [Related]
28. Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression.
Xu Y; Tao J; Yu X; Wu Y; Chen Y; You K; Zhang J; Getachew A; Pan T; Zhuang Y; Yuan F; Yang F; Lin X; Li YX
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622799
[TBL] [Abstract][Full Text] [Related]
29. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
[TBL] [Abstract][Full Text] [Related]
30. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
[TBL] [Abstract][Full Text] [Related]
31. A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitro.
Zhao W; Jaganathan S; Turkson J
J Biol Chem; 2010 Nov; 285(46):35855-65. PubMed ID: 20807764
[TBL] [Abstract][Full Text] [Related]
32. Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells.
Muromoto R; Kuroda M; Togi S; Sekine Y; Nanbo A; Shimoda K; Oritani K; Matsuda T
Eur J Immunol; 2010 Dec; 40(12):3570-80. PubMed ID: 21108476
[TBL] [Abstract][Full Text] [Related]
33. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
34. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings.
Seki E; Kondo Y; Iimuro Y; Naka T; Son G; Kishimoto T; Fujimoto J; Tsutsui H; Nakanishi K
J Hepatol; 2008 Feb; 48(2):237-45. PubMed ID: 18068850
[TBL] [Abstract][Full Text] [Related]
36. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
Wu X; Cao Y; Xiao H; Li C; Lin J
Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.
Wang X; Veeraraghavan J; Liu CC; Cao X; Qin L; Kim JA; Tan Y; Loo SK; Hu Y; Lin L; Lee S; Shea MJ; Mitchell T; Li S; Ellis MJ; Hilsenbeck SG; Schiff R; Wang XS
Clin Cancer Res; 2021 May; 27(9):2648-2662. PubMed ID: 33542078
[TBL] [Abstract][Full Text] [Related]
38. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
39. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase.
Boulton TG; Zhong Z; Wen Z; Darnell JE; Stahl N; Yancopoulos GD
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6915-9. PubMed ID: 7624343
[TBL] [Abstract][Full Text] [Related]
40. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C
Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
